Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
about
Targeting Protein-Protein Interactions in the HIF SystemOpen access chemical probes for epigenetic targetsProtein lysine acetylation by p300/CBPDiscovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration AnalysisGeneration of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia TherapyCBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine AcetylationPredictions of Ligand Selectivity from Absolute Binding Free Energy CalculationsSensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibitionStructural diversity of the epigenetics pocketome.Epigenetic stress responses induce muscle stem-cell ageing by Hoxa9 developmental signals.ETS-targeted therapy: can it substitute for MEK inhibitors?Epigenetic Strategies to Boost Cancer Immunotherapies.Identification of Covalent Bromodomain Binders through DNA Display of Small Molecules.BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.Chromatin signatures at Notch-regulated enhancers reveal large-scale changes in H3K56ac upon activation.CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responsesMapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk.Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112.Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.Selective targeting of Bromodomains of the Bromodomain-PHD Fingers family impairs osteoclast differentiation.Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.Progress in the Development of non-BET Bromodomain Chemical Probes.Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myelomaEpigenetic regulation of cardiac fibrosis.Selective targeting of epigenetic reader domains.Epigenetics: A primer for clinicians.Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development.Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology.Structural features and inhibitors of bromodomains.Bromodomain inhibitors and cancer therapy: From structures to applications.Discovery of New Bromodomain Scaffolds by Biosensor Fragment Screening.Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomainStructure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B.Hot-spot identification on a broad class of proteins and RNA suggest unifying principles of molecular recognition.Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.
P2860
Q26753176-811FF93A-88CF-4FED-B8F0-3F00CB6B122AQ26781872-0AB98529-1885-422F-8C58-FB02B3959161Q27021749-082ABEEE-7AE3-454C-BBF9-532E0E17FB55Q27728041-FFE478A7-7AD8-47E2-8141-0D47D63A0B45Q28269627-EF5E3DA0-CC26-4AE1-8A2E-103D3E5FA04DQ28818241-A77A79B3-C634-48C3-942F-A752D5E51990Q28818600-511EC25B-A321-4CB6-97A6-E9D0B77F7CC6Q28829718-2E640382-3920-41DD-A87B-10331A6F1407Q30487951-EEC3AB79-EEB3-4CCE-85BE-B0DFE0C03FB2Q33633254-7C7A9D9B-87C9-406B-BA1D-CD183E450B60Q33638827-5BB2A2B1-01B3-4134-A38C-8DD2EB28BAE8Q33838340-3374E3D7-4E5C-4644-B5A4-DF08668350BAQ35577550-F4E09637-D965-45B1-A99C-C61906CA0BE2Q35762941-0E367BCC-CF0E-4E47-93B5-BBAE95548934Q35885359-6AFB6AA8-E9E4-421A-9690-EF3BFB4C395AQ35991641-DEB63381-0019-4B96-B21D-0DC0EA398303Q36008355-974459B6-391E-4970-BC59-31F348052385Q36012341-651E1984-A9A4-453A-BDEC-C85A80F5ADB2Q36586506-8948CA2E-FAE5-40B4-9A94-6DD445547A29Q37223691-42B97A0F-219E-4E3E-AB73-E83E664C6DC4Q37334404-E593129E-645B-489A-816A-E99D97045CE5Q38604141-A6913EFE-D7EF-4AEB-A8F1-C390E21ECFE3Q38668625-1C2A0447-4C3B-4D07-972A-7340276AD534Q38691377-2A5F4163-FA42-4B33-9167-5FE98BB16FEFQ38692457-042D20A8-0793-4424-9536-669A0DA2841FQ38729035-A74CD582-2D42-4BD3-BC42-A8AF27FBF283Q38733315-7B2B6098-A344-4480-BD07-F72D5110159FQ38748150-724BDF21-976A-4397-AA02-8FC244C605B1Q38770916-CD83444B-8B0A-4453-A0F1-AE85B1CF7FD0Q38771703-471668DB-CAE4-482A-93D9-7224C99B736CQ38837561-1C65CC51-C2A1-46D4-A479-CB1D476D99CFQ38987705-DD748AFC-1693-42ED-B223-1C3C3C6205DAQ39027056-BAB8E73C-7711-478C-A9A0-395C5C945CE2Q39085471-75DB6237-6F31-4A16-BF95-634C154D7AD7Q39423291-25F2F1E9-D6E9-4DC3-B97D-C1D543B9667CQ39809867-6094BE96-98F6-4C50-9DCE-DD22D1F14E05Q40977903-D1AE15EB-6731-45D3-BAF0-909A7F52AAAAQ41512122-39F143E6-9978-45CC-BDE2-DF628C3FF651Q42513461-8BFCB645-E25B-4507-BC07-477099C6EDBAQ42540410-9CBB177F-5641-4830-BB0A-6BDB0CE6CED3
P2860
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@ast
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@en
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@nl
type
label
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@ast
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@en
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@nl
prefLabel
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@ast
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@en
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@nl
P2093
P2860
P50
P3181
P356
P1476
Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains
@en
P2093
Anthony Tumber
Catherine M Rogers
Christopher Wells
Clarence Yapp
Cynthia Tallant
Dean C Singleton
Duncan A Hay
Mark E Bunnage
Martin Philpott
Octovia P Monteiro
P2860
P304
P3181
P356
10.1021/JA412434F
P407
P577
2014-07-02T00:00:00Z